Evidence map›Paper›PMID 32912836›Full record

ReviewRedox biology2020

S-glutathionylation, friend or foe in cardiovascular health and disease.

N A Rashdan, B Shrestha, C B Pattillo

Open access · goldAbstract readReview
In one paragraph

Review in Redox biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. [Exogenous nitric oxide suppresses KSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article
  3. Post‑translational modifications in diabetic kidney disease (Review).International journal of molecular medicine · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

N A RashdanDepartment of Cellular and Molecular Physiology, Louisiana State Health Science Center, Shreveport, LA, USA.
B ShresthaDepartment of Cellular and Molecular Physiology, Louisiana State Health Science Center, Shreveport, LA, USA.
C B PattilloDepartment of Cellular and Molecular Physiology, Louisiana State Health Science Center, Shreveport, LA, USA. Electronic address: cpatt7@lsuhsc.edu.
Louisiana State University Health Sciences Center Shreveport · US

Funding

Cellular Reductive State Regulates ArteriogenesisR01HL139755 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI PATTILLO, CHRISTOPHER BRUCE · 2019 to 2023
$1.8M
NHLBI NIH HHS R01 HL139755
6 · The paper itself

Abstract

Glutathione is a low molecular weight thiol that is present at high levels in the cell. The high levels of glutathione in the cell make it one of the most abundant antioxidants contributing to cellular redox homeostasis. As a general rule, throughout cardiovascular disease and progression there is an imbalance in redox homeostasis characterized by reactive oxygen species overproduction and glutathione underproduction. As research into these imbalances continues, glutathione concentrations are increasingly being observed to drive various physiological and pathological signaling responses. Interestingly in addition to acting directly as an antioxidant, glutathione is capable of post translational modifications (S-glutathionylation) of proteins through both chemical interactions and enzyme mediated events. This review will discuss both the chemical and enzyme-based S-glutathionylation of proteins involved in cardiovascular pathologies and angiogenesis.

Indexed as

AntioxidantsGlutathioneOxidation-ReductionProtein Processing, Post-TranslationalReactive Oxygen SpeciesAntioxidantsGlutathioneReactive Oxygen SpeciesCardiovascular diseaseGlutathioneS-glutathionylation

Identifiers

PMID32912836
PMCPMC7767732
OpenAlexW3080631655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.